Unfortunately 12 minutes seems to be the case. Hopefully we'll get an extended session like Annovis. We'll have to be presenting something "new" though, like them. We'll see. Looking forward to it.
Most conferences of this size will have 3-6 scientific sessions going on concurrently, with different emphasis. Each session is usually chaired by 2 scientists. They give a very brief 1 minute preview of what's to be presented. Then each talk is usually 10-15 minutes (12 is typical, 7 minutes is very short) with the last 1-2 minutes of each slot for 1-2 questions. After all the talks in that scientific session are complete, the speakers come back on stage and there is open Q/A for another 15-20 minutes. So from the schedule it looks like Sabbagh will speak Sunday 4:27 to 4:39 and probably will get a couple questions at the end (5:15 to 5:40). The total session with presentations is 90 minutes I think his talk, will have a good sized audience. Generally the P2 and P3 presentations have more people attending than the esoteric talks and will be held in a bigger room to accommodate. Its good to see the ADCS-ADL finally presented. As already inferred, based on its absence from prior PR's, this endpoint with LSM/MMRM statistics had a wide miss (p=.23). Hopefully the slides will add even more color than this and not just re-present the September 2023 PR --i.e. let's see the final n's; 30 vs 50 mg; S1R WT vs Q2P. https://alz.confex.com/alz/2024/meetingapp.cgi/Paper/90729
Dr. Jin's talk Monday July 28 at 8:20 is actually being presented by a colleague so he will not be on stage. From the abstract, A273 data may not be presented. Looks like they are mostly talking about composite endpoints and using the combined z-test stats. Given the abstract, looks like they will be commenting on donanemab. It is slated for 10 minutes https://alz.confex.com/alz/2024/meetingapp.cgi/Session/12905
the Annovis PR does not match the agenda and both have the same time. Looks like the whole session is 45 minutes but the talk is only 7 minutes plus maybe a couple questions after the last talk. https://alz.confex.com/alz/2024/meetingapp.cgi/Session/13177
News 
Market Data 
Discover 
AI
